Xiaobing Luo

Title: Innovations by Xiaobing Luo

Introduction

Xiaobing Luo is a notable inventor based in Rockville, MD (US). He has made significant contributions to the field of biomedical engineering, particularly in the development of innovative therapies for autoimmune disorders and cancer. With a total of 2 patents, his work is paving the way for advancements in targeted treatments.

Latest Patents

Luo's latest patents include bispecific chimeric antigen receptors targeting CD20 and BCMA. These innovative CARs comprise an scFv targeting CD20 and an scFv targeting BCMA, along with a hinge region, a transmembrane domain, a co-stimulatory region, and a cytoplasmic signaling domain. The chimeric antigen receptors can be utilized to treat autoimmune disorders or cancer, showcasing the potential of his inventions in improving patient outcomes.

Career Highlights

Xiaobing Luo is currently associated with Abelzeta Inc., where he continues to push the boundaries of medical technology. His work is characterized by a commitment to developing effective solutions for complex health issues. His contributions have been instrumental in advancing the understanding and treatment of various diseases.

Collaborations

Luo collaborates with talented individuals such as Yihong Yao and Jiaqi Huang. Together, they work towards innovative solutions that can significantly impact the medical field.

Conclusion

Xiaobing Luo's contributions to the field of biomedical engineering through his patents and collaborations highlight his role as a leading inventor. His work continues to inspire advancements in targeted therapies, making a meaningful difference in the lives of patients.